Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 06/18/2013

Company Name Symbol %Change
STAAR SURGIC STAA
10.98%
DTS INC DTSI
6.89%
ANIKA THERAP ANIK
6.04%
LUMOS NETWOR LMOS
5.70%
INSTEEL IND IIIN
5.28%

Two Wall Street Biggies Sued

by Zacks Equity Research

April 13, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

On Wednesday, Bank of America Corporation (BAC - Analyst Report) along with U.S. Bancorp (USB - Analyst Report) was sued by a Chicago pension fund. The complaint lodged claims that these two Wall Street Giants refrained from their duties on regular basis as the trustees for mortgage-backed bonds of Washington Mutual Inc.

Chicago-based the Policemen’s Annuity and Benefit Fund alleged that BofA and U.S. Bancorp failed in their roles and did not accurately administer 41 Washington Mutual trusts backed by home loans. Due to the ignorance of these banks, the investors suffered huge losses. U.S. Bancorp succeeded BofA as trustee for these mortgage bonds.

The pension fund invested in six of the total trusts and faced significant losses. The trustee’s key role is to look after all the loan documents and distribute payments received from servicers to the bondholders. But, the fund claimed that both banks were unsuccessful in holding the loan files. Moreover, they even did not focus on the completeness of the documents and enforcing Washington Mutual to repurchase defective loans in those trusts.

The fund has filed the lawsuit in Manhattan federal court and demanded justice for the investors. Though no arguments has been received from BofA, U.S. Bancorp spokeswoman accused the complaint as baseless. According to U.S. Bancorp, the complaint filed contains various misrepresentations of the bank’s role as trustee. Therefore, U.S. Bancorp will fight for the allegations imposed.

Earlier this month, the federal judge in New York rescinded the bid filed by the Bank of New York Mellon Corp. (BK - Analyst Report) regarding the dismissal of a lawsuit charged against the bank. The lawsuit accused the company of failing to perform its responsibilities as the trustee for investors in Countrywide Financial Corp. mortgage bonds. The Chicago fund was one of the plaintiffs.

In July 2008, Countrywide was purchased by BofA. Following this, most of the operations of Washington Mutual were bought by JPMorgan Chase & Co (JPM - Analyst Report) on its failure.

At the beginning of earnings season, such accusations on Wall Street biggies will negatively affect the banking stocks and their reputation in the market. Moreover, it would dent the banks’ financials and loosen up the investors’ confidence.

BofA currently retains a Zacks #3 Rank, which translates into a short-term ‘Hold’ rating, while U.S. Bancorp retains a Zacks #1 Rank (a short-term ‘Strong Buy’ rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.